measle type rash/raised, had pus, plus hives with it; headache; itching; This is a spontaneous report from a contactable nurse (patient).A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 intramuscular, administered in Deltoid Left on 02May2021 10:00 (Batch/Lot number was not reported) as 1ST DOSE 0.3ML, SINGLE for covid-19 immunisation.  Medical history included blood pressure. Concomitant medication(s) included atorvastatin (LIPITOR [ATORVASTATIN]) taken for blood pressure, start and stop date were not reported. She knew she could have a rash, but after 30 minutes she had a headache and took Tylenol. She mentioned she had a measel type looking rash. It was really bad. She did not say anything about it at first, just kept fighting through it. It was so bad she had to take 100mg Benadryl to try and control the itch for several days She is afraid to get the second shot on the 23rd. She is debating on going through with it. She is still having itching symptoms, but its not as bad. She is able to control it with steroid cream and lidocaine. Email: Declined to provide Weight: Knocking on on 200 pounds The events started on the same date of the vaccine which she later clarified was 02May2021. Measle type rash: At first it was getting worse and worse, but initially stated now it is about the same. It was raised and runny, but now it is drying a tad bit. It was raised, had pus, plus hives with it. Its still raised and red. It was a thick layer of measles. It was one layer on top of another. She mentioned this to a doctor at the clinic she works with. Started 30 minutes after the vaccine, but within 1 hour time frame it was getting. Her husband noticed she was starting to scratch and he questioned her about. By 11:00 it was full blown.Seriousness Criteria: When probed for seriousness criteria she felt it was really serious, but she hates going to the hospital . She decided she would watch her own symptoms until she could not anymore. If it did not get any better within the week she would go and get checked out. However, she did have a doctor at her clinic look at it and he questioned her about the rash. He asked her if she has having anything else and she said this was just about it. The doctor said it was a pretty good rash. She later stated the rash is looking better now. If the doctor reacted more to it she would have done more, but he just kept saying he hoped it was not more than that. Itching: She had itching a long with the rash, but the itching is getting better. Headache: It started and stopped the same date of the vaccine. The headache\ was more so annoying . If it was more severe she would have gone to hospital. Normally she does not get headaches. She knew it was not from the norm, but she was able to watch it on her own. Within 2-3 hours it was a light headache more so and then after the whole day it was not there. It was a different kind of headache It was a pounding headache. She does not have her vaccination card with her to provide lot/exp/NDC. She is currently at her sons house. Indication: Mentioned she was reluctant to get it at first. She was saying initially she was not going to take it, but she had a stat over at the COVID clinic where she works. She heard stories and people were asking her if she had her vaccine. They are the ones promoting it. She felt crazy saying no she did not and would just say she would get it later. She held true to her word. She is exposed to people and wanted to be safe for them and herself. Concomitant Medication: Lipitor: It was brought on by COVID. She has been monitoring her blood pressure lately due to COVID and the things she is going through. She questioned what was going on. She informed her doctor of this and was informed she should be started on a low does and to see how things are on it. She clarified and confirmed this is what she meant by it was brought on by covid. She clarified it was due to blood pressure issues due to patient workload.The outcome of measle type rash was unknown, of headache was recovered, of itching was recovering.  Follow-up attempts are completed; information about lot/batch number cannot be obtained.; Sender's Comments: The events measeles like rash, headache and pruritis was considered related to suspect drug based on strong temporal association and known safety profile of the drug.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Committees, and Investigators, as appropriate.